Eupraxia Pharmaceuticals, Inc. (EPRX)
7.50
+0.05
(+0.67%)
USD |
NASDAQ |
Sep 03, 16:00
7.50
0.00 (0.00%)
After-Hours: 20:00
Eupraxia Pharmaceuticals Total Liabilities (Quarterly) : 10.23M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.23M |
| March 31, 2026 | 9.166M |
| December 31, 2025 | 5.704M |
| September 30, 2025 | 3.906M |
| June 30, 2025 | 2.618M |
| March 31, 2025 | 2.20M |
| December 31, 2024 | 3.103M |
| September 30, 2024 | 2.387M |
| June 30, 2024 | 11.64M |
| March 31, 2024 | 18.53M |
| December 31, 2023 | |
| September 30, 2023 | 14.27M |
| June 30, 2023 | 11.08M |
| March 31, 2023 | 9.472M |
| Date | Value |
|---|---|
| December 31, 2022 | 10.71M |
| September 30, 2022 | 9.003M |
| June 30, 2022 | 10.43M |
| March 31, 2022 | 8.710M |
| December 31, 2021 | 9.238M |
| September 30, 2021 | 9.530M |
| June 30, 2021 | 7.753M |
| March 31, 2021 | 6.239M |
| December 31, 2020 | 18.15M |
| September 30, 2020 | 17.03M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 16.52M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Edesa Biotech, Inc. | 3.91M |
| ProMIS Neurosciences, Inc. | 7.295M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 139.91M |
| Shareholders Equity (Quarterly) | 131.28M |
| Debt to Equity Ratio | 0.014 |
| Current Ratio | 16.00 |
| Net Debt Paydown Yield | -0.08% |